Hostname: page-component-7b7567c8c-fvjsw Total loading time: 0 Render date: 2026-11-17T09:50:04.432Z Has data issue: false hasContentIssue false

Control of Endemic Glycopeptide-Resistant Enterococci

Published online by Cambridge University Press:  02 January 2015

Louise M. Dembry
Affiliation:
Department of Internal Medicine, Detroit, MichiganDivision of Infectious Diseases, Detroit, MichiganWayne State University School of Medicine, Detroit, MichiganThe Yale University School of Medicine, New Haven, Connecticut
Keke Uzokwe
Affiliation:
Department of Internal Medicine, Detroit, MichiganDivision of Infectious Diseases, Detroit, MichiganThe William Beaumont Hospital, Royal Oak, Michigan
Marcus J. Zervos
Affiliation:
Department of Internal Medicine, Detroit, MichiganDivision of Infectious Diseases, Detroit, MichiganWayne State University School of Medicine, Detroit, MichiganThe William Beaumont Hospital, Royal Oak, Michigan

Abstract

Objective: To evaluate the epidemiology of, and control measures for, vancomycin-resistant Enterococcus (VRE) in a renal unit.

Design: A 3-month, prospective, prevalence culture survey of patients on a 24-bed renal unit.

Setting: A 975-bed community teaching hospital.

Patients: Patients admitted to the renal unit over a 3-month period. Patients identified with VRE were each matched with four patients without VRE isolated over the study period.

Interventions/Control Measures: Resistant-organism barrier precautions. To eradicate carriage of VRE, two patients with VRE stool colonization were treated with 5 days of oral doxycycline (100 mg twice per day) and rifampin (300 mg/day).

Results: Seven patients with VRE (8 isolates) were identified. Five isolates were Enterococcus faecium (vancomycin MIC=16 to 256 μg/mL), two were Enterococcus faecalis (MICs=16 and 124 μg/mL), and one was Enterococcus gallinarum (MIC=8.0 μg/mL). Eradication of carriage with VRE was accomplished in two patients treated with doxycycline and rifampin. In the final 30 days of the culture survey and at 9 months, there were no further patients with VRE identified.

Conclusions: Resistant-organism precautions and elimination of patient carriage may be useful measures for controlling the spread of low-prevalence endemic vancomycin-resistant Enterococcus.

Information

Type
Original Articles
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1996 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable